Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammation

Inflammation

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

What is the Immune System?

What is the Immune System?

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Humoral Immune Responses

Humoral Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case report.

Annals of hematology·2026

Same author

Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.

ESMO open·2026

Same author

Communication Training for Dental Students.

JDR clinical and translational research·2025

Same author

Optical and acoustic plasmons in the layered material Sr<sub>2</sub>RuO<sub>4</sub>.

Nature communications·2025

Same author

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Leukemia·2025

Same author

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same journal

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026

Same journal

[Effects of air pollution on cardiovascular health].

Herz·2026

Same journal

[Heart and climate].

Herz·2026

Same journal

Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

Herz·2026

Same journal

[Noise and the heart].

Herz·2026

Same journal

[The cardiovascular exposome: areas of action for prevention and practical cardiology].

Herz·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 28, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

[Immunity and inflammation in atherosclerosis].

D Wolf^1,2, K Ley^3,4

¹Abteilung für Kardiologie und Angiologie I, Universitäts-Herzzentrum Freiburg, Freiburg, Deutschland.

|March 13, 2019

Summary

This summary is machine-generated.

Arteriosclerosis is a chronic inflammatory disease. Research highlights how adaptive immunity influences its development, emphasizing the need for better animal models for human atherosclerosis treatment.

Keywords:

Animal models Blood vessels Immune system Lymphocytes Vaccination

More Related Videos

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Related Experiment Videos

Last Updated: Jan 28, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Area of Science:

Immunology
Cardiovascular Disease Research
Pathogenesis Studies

Background:

Arteriosclerosis is increasingly recognized as a chronic inflammatory condition.
Both innate and adaptive immune responses play critical roles in modulating arteriosclerosis progression.
Recent advancements provide deeper insights into these immune mechanisms.

Purpose of the Study:

To summarize and discuss the pathogenesis of arteriosclerosis.
To specifically focus on the role of the adaptive immune system in arteriosclerosis.
To address limitations in current animal models for studying human atherosclerosis.

Main Methods:

Review of experimental and clinical evidence.
Analysis of findings from genome-wide association studies.
Incorporation of data from advanced in vivo imaging and transgenic mouse models.

Main Results:

Experimental and clinical data strongly support arteriosclerosis as an inflammatory disease.
Adaptive immune mechanisms significantly impact the acceleration or inhibition of arteriosclerosis.
Current animal models have limitations in accurately reflecting human atherosclerosis.

Conclusions:

The adaptive immune system is a key player in arteriosclerosis pathogenesis.
Improved, human-relevant animal models are crucial for advancing atherosclerosis prevention and treatment.
Further research is needed to translate findings into effective clinical interventions.